Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

for
Malignant Female Reproductive System Neoplasm,
Location: Houston TX, Baltimore MD
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03968406

Phase1, Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

for
Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia
Location: Houston TX, Durham NC, Cleveland OH, Salt Lake City UT,
Sponsor: Karyopharm Therapeutics Inc

Sex: All

Age: 18+

Code: NCT05980806

Phase2, Recruiting

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

for
Solid Tumor, Adult, Mesothelioma, NSCLC
Location: Houston TX, San Antonio TX, Chicago IL, Minneapolis MN,
Sponsor: Vivace Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT04665206

Phase1, Phase2, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Houston TX, New Orleans LA, Oklahoma City OK,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase2, Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumor
Location: Houston TX, Austin TX, Grand Rapids MI, Fort Worth TX,
Sponsor: Pliant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06270706

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Houston TX, Austin TX, Temple TX, Corpus Christi TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

for
Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia,
Location: Houston TX, Miami FL
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06566742

Phase2, Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

for
Metastatic Small Intestinal Adenocarcinoma,
Location: Houston TX, Lawton OK, Little Rock AR, Fort Smith AR,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04205968

Phase2, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Houston TX, Austin TX, Temple TX, Corpus Christi TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Houston TX, Austin TX, Temple TX, Corpus Christi TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Houston TX, San Antonio TX, Nashville TN, St Louis MO,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06952010

Phase1, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Webster TX, New Braunfels TX, San Antonio TX,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Houston TX, Columbus OH, Grand Rapids MI,
Sponsor: Tanabe Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06943521

Phase1, Phase2, Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for
Advanced Solid Tumor, PDAC, HNSCC
Location: Houston TX, San Antonio TX, Rogers AR, St Louis MO,
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06597721

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

for
Solid Tumor
Location: Houston TX, Dallas TX, Glendale CA
Sponsor: Teligene US

Sex: All

Age: 18+

Code: NCT06010342

Phase2, Recruiting

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for
Solid Tumors
Location: Houston TX, Irving TX, Jacksonville FL, Rochester MN,
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Sex: All

Age: 18 - 70+

Code: NCT06963281

Phase1, Recruiting

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, EGFR Positive Solid Tumors, EGFR
Location: Houston TX, Scottsdale AZ
Sponsor: Vir Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06960395

Phase1, Recruiting

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

for
Malignant Primary Pelvic Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT05134142

Recruiting

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: Houston TX, Pearland TX, Pasadena TX, Austin TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT06920043

Phase2, Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

for
Refractory Rheumatoid Arthritis (RA),
Location: Bellaire TX, Katy TX, Woodland TX, Red Oak TX,
Sponsor: Artiva Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06991114

Phase2, Recruiting